Pediatrics
News from the FDA/CDC
FDA approves ixekizumab for pediatric plaque psoriasis
A phase 3 study showed a safety profile similar in both pediatric and adult patients, albeit with greater rates of conjunctivitis, influenza, and...
News from the FDA/CDC
Flu activity measures continue COVID-19–related divergence
Fewer samples are testing positive, but flu-related visits are increasing.
From the Journals
Reports suggest possible in utero transmission of novel coronavirus 2019
Three neonates whose mothers had COVID-19 had elevated IgM antibody concentrations.
From the Journals
Despite strict controls, some infants born to mothers with COVID-19 appear infected
But the sources of novel coronavirus 2019 in the neonates’ upper respiratory tracts or anuses likely were maternal in origin.
Conference Coverage
Oral propranolol shown safe in PHACE
LAHAINA, HAWAII – Intervention for infantile hemangiomas recommended within first month of age.
Conference Coverage
Don’t call it perioral dermatitis
LAHAINA, HAWAII – Periorificial dermatitis is a better moniker for the acne mimicker.
Conference Coverage
New topicals coming for pediatric atopic dermatitis
LAHAINA, HAWAII – Novel noncorticosteroid topicals will fill an unmet need in atopic dermatitis.
Commentary
Preventable diseases could gain a foothold because of COVID-19
Measles and influenza are two deadly infectious diseases for which there are vaccines.
From the Journals
COVID-19 in China: Children have less severe disease, but are vulnerable
The findings of this case review underscore the possibility that children “may play a major role in community-based viral transmission” of novel...
Opinion
COVID-19 guidance for children’s health care providers
Accurate information calmly delivered is the antidote to anxiety or panic in a stressful situation.
Conference Coverage
Dupilumab approval sought for AD under age 12
LAHAINA, HAWAII – First biologic approved for atopic dermatitis is under study down to age 2 years.